SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 36 filers reported holding SATSUMA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $68,000 | +44.7% | 11,300 | -0.9% | 0.00% | – |
| Q2 2022 | $47,000 | -42.0% | 11,400 | -47.0% | 0.00% | -100.0% |
| Q1 2022 | $81,000 | +28.6% | 21,500 | +53.6% | 0.00% | 0.0% |
| Q4 2021 | $63,000 | -6.0% | 14,000 | -1.4% | 0.00% | 0.0% |
| Q3 2021 | $67,000 | -22.1% | 14,200 | -1.4% | 0.00% | 0.0% |
| Q1 2021 | $86,000 | +19.4% | 14,400 | -7.7% | 0.00% | 0.0% |
| Q4 2020 | $72,000 | -88.6% | 15,600 | -29.1% | 0.00% | -87.5% |
| Q2 2020 | $634,000 | – | 22,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,711,286 | $22,268,000 | 3.58% |
| NEA Management Company, LLC | 3,142,958 | $18,858,000 | 0.94% |
| Vivo Capital, LLC | 1,232,394 | $7,394,000 | 0.82% |
| RA Capital Management | 5,914,252 | $35,486,000 | 0.76% |
| Nan Fung Group Holdings Ltd | 177,900 | $1,067,000 | 0.68% |
| Ikarian Capital, LLC | 400,000 | $2,400,000 | 0.48% |
| SAMLYN CAPITAL, LLC | 2,929,195 | $17,575,000 | 0.33% |
| EAM Investors, LLC | 149,029 | $894,000 | 0.19% |
| TPG GP A, LLC | 1,885,939 | $11,316,000 | 0.18% |
| Ikarian Capital, LLC | 136,059 | $815,000 | 0.16% |